CAN THE TISSUE FACTOR EXPRESSION USED AS A PREDICTIVE VALUE TO DETERMINE THE THROMBOEMBOLIC RISK OF MSC THERAPIES?

Autor:	Araldi, RP1,2 (AUTHOR), Prezoto, BC1 (AUTHOR), Paiva, P2 (AUTHOR), Gonzaga, V1 (AUTHOR), Lisboa, NCM2 (AUTHOR), Policiquio, B1 (AUTHOR), Pagani, E2 (AUTHOR), Wenceslau, CV2 (AUTHOR), D'Amelio, F1 (AUTHOR), Kerkis, I1 (AUTHOR)
Zdroj:	Cytotherapy (Elsevier Inc.). Apr2021 Supplement, Vol. 23, p5-6. 2p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect